Matthew Alvarez, MD
Obstetrics & Gynecology · Raleigh, NCNPI 1013022946
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by BD at 44.1% of the total. Reporting peaked in 2024 at $679 and has fallen 60.0% since, to $271 in 2025.
Across 42 payments — averaging $29.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$550
- Bayer$151
- Coopersurgical, Inc.$78
- Pfizer$68
- Astellas Pharma US Inc$60
- Vertical Pharmaceuticals, LLC$37
- plus $303 from 14 others
What the payments were for
- Speaking & faculty fees$55044%
- Food & beverage$67054%
- Education$262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 1 | $550 |
| Bayer | 10 | $151 |
| Coopersurgical, Inc. | 4 | $78 |
| Pfizer | 4 | $68 |
| Astellas Pharma US Inc | 3 | $60 |
| Vertical Pharmaceuticals, LLC | 2 | $37 |
| Merck | 2 | $35 |
| Exeltis, USA Inc. | 2 | $34 |
| Biogen | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| AMAG Pharmaceuticals, Inc. | 2 | $26 |
| Mylan Pharmaceuticals Inc. | 2 | $24 |
| Vertex | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| AbbVie | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Millicent US Inc | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$1,246 in reported general payments places this provider in the 65th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $1,170 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Raleigh
- Jack IngeRaleigh$157K
- Robert LittletonRaleigh$61K
- Elizabeth CovielloRaleigh$26K
- Tanneisha BarlowRaleigh$13K
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Geeta SwamyDurham$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.